scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/978-3-642-66956-9_3 |
P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/978-3-642-66956-9_3 |
P698 | PubMed publication ID | 97054 |
P2093 | author name string | G. R. Pearson | |
P2860 | cites work | QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING Cr51-LABELLED TARGET CELLS | Q78330506 |
Lymphocyte-dependent antibodies | Q93731367 | ||
Tissue Localization of Lymphocytes Bearing a Membrane Receptor for Antigen-Antibody-Complement Complexes | Q33707286 | ||
Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms | Q35031252 | ||
Augmentation of lymphocyte cytotoxicity by antibody to herpesvirus saimiri associated antigens | Q35077693 | ||
Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases | Q35902663 | ||
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics | Q36271479 | ||
Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system | Q36271498 | ||
The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection | Q36272260 | ||
Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells | Q36272788 | ||
Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes | Q36335190 | ||
IgM-induced tumor cell cytotoxicity mediated by normal thymocytes | Q36358264 | ||
Lymphocyte-dependent antibody cross-matching for transplant patients | Q39315458 | ||
Lymphocyte-dependent antibody and renal graft rejection | Q39324880 | ||
In Vitro Target Cell Lysis Mediated by Normal Human Lymphocytes (K Cells) or Monocytes | Q39369931 | ||
Interaction Analysis of Selective and Nonselective Cell-Mediated Cytotoxicity23 | Q39412410 | ||
Inability of normal and activated thymus-derived cells to act as cytotoxic effector cells against antibody-coated targets | Q39790495 | ||
Cytotoxic effects of lymphoid cells in vitro | Q39905652 | ||
Antibody-dependent lymphocyte mediated cytotoxicity mechanism and modulation by cyclic nucleotides | Q39967279 | ||
Kinetics of serum factors mediating blocking, unblocking and antibody-dependent cellular cytotoxicity in hamsters given isografts of para-7 tumor cells | Q39979188 | ||
Antibody-Dependent Lymphocyte Cytotoxicity Against Cells Expressing Epstein—Barr Virus Antigens | Q39980256 | ||
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections | Q39994582 | ||
Immune destruction of virus-infected cells early in the infectious cycle | Q40010383 | ||
Antibody responses to membrane antigens in monkeys infected withherpesvirus saimiri | Q40027092 | ||
Tumour-specific antibodies reactive with cell-surface antigens in children with wilms' tumour | Q40058435 | ||
Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays | Q40072912 | ||
Inhibition of lymphocyte-dependent antibody effector cell function by human anti-B-lymphocyte alloantiserum | Q40640635 | ||
Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells | Q40641091 | ||
Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma | Q41071263 | ||
A new surface marker on T lymphocytes of human peripheral blood | Q41975968 | ||
Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker | Q42836753 | ||
Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood | Q42941074 | ||
Destruction of dextran-coated target cells by normal human lymphocytes and monocytes. Induction by a human anti-dextran serum with IgG antibodies restricted to the IgG2 subclass | Q43492756 | ||
The Nonselective Cytotoxic Cell (N Cell) 2 | Q43493469 | ||
A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma | Q43554398 | ||
Identification of lymphocyte-dependent antibody in sera from multiply transfused patients. | Q43715230 | ||
The role of lymphocyte-dependent antibody in kidney transplantation | Q44672210 | ||
Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM | Q44728919 | ||
Antibody-dependent lymphocyte-mediated cytotoxicity (Ab-LMC), definition of the "K cell" in the rat | Q44782246 | ||
Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell | Q44798371 | ||
Immunotherapy of primary moloney sarcoma-virus-induced tumors | Q45811706 | ||
The immune response to primary moloney sarcoma virus tumors in BALB/C mice: Cellular and humoral activity of long-term regressors | Q45816246 | ||
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus | Q45817934 | ||
Immunological destruction of herpes simplex virus I infected cells | Q45818043 | ||
Antibody-Dependent, Cell-Mediated Cytotoxicity With Autochthonous Lymphocytes and Sera After Infection With Moloney Sarcoma Virus2 | Q45882106 | ||
Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract. | Q47824344 | ||
Localisation of Monocyte Binding Site of Human Immunoglobulin G | Q47881396 | ||
Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. | Q52258895 | ||
Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells | Q52833871 | ||
Antibody and Cell Requirements for Cytotoxicity by Non-Immune Effector Cells | Q53766997 | ||
A class of specific cytotoxic cells demonstrated in vitro by arming with antigen-antibody complexes. | Q53794446 | ||
Lymphocyte-dependent cytotoxic antibody activity against human transplantation antigens. | Q54722140 | ||
Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells | Q54733654 | ||
In vitro Cytotoxic Effect of Lymphoid Cells from Mice Immunized with Allogeneic Tissue | Q59059826 | ||
Different effector cell types in antibody-dependent cell-mediated cytotoxicity | Q59072263 | ||
Effect of Specific Antibody to Target Cells on their Specific and Non-specific Interactions with Lymphocytes | Q59085674 | ||
Studies of lymphocyte-dependent antibodies to leukemia-associated antigens using frozen stored leukemia target cells | Q66857831 | ||
A comparison of the effects of metabolic inhibitors upon direct and antibody-dependent lymphocyte mediated cytotoxicity | Q66880741 | ||
Expression of a receptor for IgM by human T cellsin vitro | Q66888067 | ||
Antibody-dependent lymphocyte-mediated cytotoxicity. The nature of the effector cell and characterization of its fc receptor | Q66888587 | ||
Antibody-Dependent Lymphoid Cell-Mediated Cytotoxicity: No Requirement for Thymus-Derived Lymphocytes | Q67273886 | ||
In vitro target cell lysis mediated by normal human lymphocytes. Influence of molecular properties and affinity of inducing antibody | Q67428568 | ||
A plaque technique for assay and characterization of antibody-dependent cytotoxic effector (K) cells | Q67473544 | ||
Antibody-dependent human lymphocytotoxicity: a micro assay system | Q67527334 | ||
Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum | Q67586358 | ||
Antibody-dependent cell-mediated cytotoxicity in rheumatoid arthritis. Effect of rheumatoid serum fractions on normal lymphocytes | Q67764320 | ||
Comparative study of antibody-dependent and direct lymphocyte-mediated cytotoxicity in vitro after alloimmunization in the human. II. Chemical inhibitors | Q68364982 | ||
Demonstration of cell-mediated immunity to human neoplasms of various histological types | Q68621300 | ||
Antibody-Induced <i>in vitro</i> Lymphocyte Cytotoxicity in Hashimoto Thyroiditis | Q68940584 | ||
Antibody-dependent lymphocyte-mediated cytotoxicity in man: no requirement for lymphocytes with membrane-bound immunoglobulin | Q69116786 | ||
Antibody dependent cellular cytotoxicity: Cytotoxicity mediated by non T-lymphocytes | Q69148772 | ||
Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells? | Q69998320 | ||
Specific killing of tumor cellsIn vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens | Q70413132 | ||
Antibody‐mediated target cell lysis by non‐immune cells. Characterization of the antibody and effector cell populations | Q70509700 | ||
A microassay for cell-mediated immunity | Q71487878 | ||
Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes | Q71709725 | ||
International Whaling Omission | Q71891815 | ||
IN VITRO CYTOTOXIC EFFECT OF ISOANTIBODY MEASURED AS ISOTOPE RELEASE FROM LABELLED TARGET CELL DNA | Q76543552 | ||
CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS | Q77148772 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
cytotoxicity | Q246181 | ||
immunologic cytotoxicity | Q60345185 | ||
P304 | page(s) | 65-96 | |
P577 | publication date | 1978-01-01 | |
P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
P1476 | title | In Vitro and in Vivo Investigations on Antibody-Dependent Cellular Cytotoxicity | |
P478 | volume | 80 |
Q30978436 | A case of facio-scapulo-humero-peroneal myopathy with inflammatory changes. Preliminary data on distribution of mononuclear cells in muscle tissue |
Q45792100 | Antibody reactive in antibody‐dependent cell‐mediated cytotoxicity following influenza virus vaccination |
Q40733384 | Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes |
Q70998008 | Antibody-dependent cell-mediated cytotoxicity. Effectors, signals, and mechanisms |
Q54388237 | Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target ce |
Q45798015 | Application of Epstein‐Barr Virus Serology to the Diagnosis and Staging of North American Patients with Nasopharyngeal Carcinoma |
Q35993739 | Cellular cytotoxicity mediated by isotype-switch variants of a monoclonal antibody to human neuroblastoma |
Q72084820 | Colony‐stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells |
Q66978173 | Cytotoxic immune response of meningioma patients towards allogeneic and autologous tumour cells before and after surgery |
Q67273072 | Decreased antibody-dependent cellular cytotoxicity in minimal change nephrotic syndrome |
Q45799776 | Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells. |
Q39584938 | Epstein-barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma |
Q33909301 | Humoral and cell-mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis |
Q72894617 | Identification of IgG-binding site on E.HIstolytica cell membrane |
Q42468311 | Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity |
Q72647229 | IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma |
Q33907414 | Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus. |
Q72857103 | Immunoglobulin a Antibody to Epstein‐Barr Viral Antigens and Prognosis in Nasopharyngeal Carcinoma |
Q41169213 | Induction of cytolytic T- and B-cell responses against influenza virus infections. |
Q72797314 | Lymphocyte function in patients with chronic glomerulonephritis. Tests of suppressive activity generation by concanavalin A and antibody-dependent cellular cytotoxicity |
Q70575014 | Modulation of antitumoral antibody-dependent cellular cytotoxicity and natural killer activity by Adriamycin and daunorubicin |
Q28249057 | Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma |
Q37007141 | Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system |
Q33903745 | Natural and immune cytolysis of canine distemper virus-infected target cells |
Q36353630 | Oxidative mechanisms of monocyte-mediated cytotoxicity |
Q45804154 | The Role of Viral Glycoproteins in Mumps Virus-Mediated Antibody-Dependent Cellular Cytotoxity in Vitro |
Q45843761 | The immune response to vaccinia virus infection in mice: analysis of the role of antibody |
Search more.